19 "Lung Disease" clinical trials found.

• A Phase 2 Multicenter, Double-blind, Randomized, Placebo-Controlled Trial to Evaluate Oral Ifetroban in Subjects with Symptomatic Aspirin Exacerbated Respiratory Disease ...

  The primary purpose of this study is to determine the therapeutic effectiveness of Ifetroban to improve sinus and nasal symptoms ...

  Exact  Phase  Laurel Doghramji

• 

  A PHASE III RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF AEROVANC FOR THE TREATMENT OF PERSISTANT METHICILLIN-RESISTANT Staphylococcus aureus LUNG INFECTION IN ...

  TBD

  Exact  Phase  Daniel J Dorgan

• 

  Determination of B-cell responsiveness to the incretin hormones GLP-1 and GIP in Cystic Fibrosis (PRIME)

  The mechanisms underlying cystic fibrosis related diabetes (CFRD) pathophysiology must be better defined if care for people with CFRD is ...

  Exact 

• 

  An extended access program to assess long-term safety of bardoxolone methyl in patients with pulmonary hypertension

  This is a Phase 3a, extended access program to assess long-term safety of bardoxolone methyl in patients with pulmonary hypertension ...

  Exact  Phase  Harold Palevsky Md

• Open-Labeled Trial Of Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Lung Transplants From Hepatitis C-Positive Donors

  There has only been a modest increase in the number of lung transplants each year, increasing from a yearly average ...

  Exact  Phase  David Goldberg

• 

  Human Respiratory Virome in Health and Lung Disease-Lung Bronchoscopy Cohort

  Humans live in a closely interdependent relationship with microbes that inhabit the human body (the human microbiome), but the viruses ...

  Exact  Phase N/A Ronald Collman Md

• 

  Intraoperative molecular imaging of pulmonary nodules by BY SGM-101

  Exact  Phase  Sunil Singhal Md

• 

  UPCC 15518 / ANAM-17-21: A Phase 3 Randomized Double-Blind Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of anamorelin HCl ...

  The main purpose of this study is to learn more about how well the experimental drug, anamorelin hydrochloride (HCl), works ...

  Exact  Phase  Ingrid Kohut

• UPCC 06518: A Phase 2 Precision Oncology Study of Biomarker-Directed Pembrolizumab-Based Combination Therapy for Advanced Non-Small Cell Lung Cancer

  To evaluate the clinical activity (as assessed by objective response rate [ORR]) pembrolizumab (MK-3475) in combination with MK-4280 or lenvatinib ...

  Exact  Phase  Charu Aggarwal

• UPCC 09517: Phase II study of Pembrolizumab and Itacitinib (INCB039110) for First Line Treatment of Metastatic Non-Small Cell Lung Cancer ...

  The main purpose of this study is to examine the efficacy of adding itacitinib (also known as INCB039110) to pembrolizumab ...

  Exact  Phase  Joshua Bauml